Zacks Research Weighs in on Tenet Healthcare Co.’s Q3 2025 Earnings (NYSE:THC)

Tenet Healthcare Co. (NYSE:THC) – Equities researchers at Zacks Research increased their Q3 2025 EPS estimates for Tenet Healthcare in a research report issued on Wednesday, October 9th. Zacks Research analyst D. Chatterjee now forecasts that the company will earn $2.21 per share for the quarter, up from their previous forecast of $2.20. The consensus estimate for Tenet Healthcare’s current full-year earnings is $10.73 per share. Zacks Research also issued estimates for Tenet Healthcare’s FY2025 earnings at $9.67 EPS.

Several other research analysts have also weighed in on THC. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Tenet Healthcare from $150.00 to $155.00 and gave the company a “buy” rating in a research note on Friday, June 28th. Citigroup increased their price target on shares of Tenet Healthcare from $139.00 to $171.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Barclays increased their price target on shares of Tenet Healthcare from $156.00 to $171.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $168.00 price objective on shares of Tenet Healthcare in a report on Tuesday, October 1st. Finally, KeyCorp assumed coverage on shares of Tenet Healthcare in a report on Friday. They set an “overweight” rating and a $200.00 price objective for the company. One research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and four have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and an average target price of $156.06.

Tenet Healthcare Stock Down 0.3 %

Tenet Healthcare stock opened at $155.29 on Monday. The firm has a market cap of $15.17 billion, a PE ratio of 6.03, a P/E/G ratio of 0.78 and a beta of 2.14. The company has a debt-to-equity ratio of 2.53, a quick ratio of 1.38 and a current ratio of 1.45. The firm’s 50 day moving average price is $158.78 and its two-hundred day moving average price is $137.31. Tenet Healthcare has a twelve month low of $51.04 and a twelve month high of $171.20.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Wednesday, July 24th. The company reported $2.31 EPS for the quarter, beating the consensus estimate of $1.89 by $0.42. The business had revenue of $5.10 billion during the quarter, compared to the consensus estimate of $4.98 billion. Tenet Healthcare had a net margin of 13.17% and a return on equity of 24.66%.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the stock. Creative Planning boosted its position in Tenet Healthcare by 2.9% in the 3rd quarter. Creative Planning now owns 16,099 shares of the company’s stock valued at $2,676,000 after buying an additional 461 shares during the last quarter. ORG Wealth Partners LLC acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $30,000. Willner & Heller LLC acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $204,000. Exchange Traded Concepts LLC acquired a new position in shares of Tenet Healthcare in the 3rd quarter valued at $421,000. Finally, Ritholtz Wealth Management lifted its stake in shares of Tenet Healthcare by 15.1% in the 3rd quarter. Ritholtz Wealth Management now owns 18,800 shares of the company’s stock valued at $3,125,000 after purchasing an additional 2,466 shares during the period. Institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In other news, insider R. Scott Ramsey sold 11,599 shares of the firm’s stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $162.06, for a total transaction of $1,879,733.94. Following the completion of the transaction, the insider now directly owns 6,324 shares of the company’s stock, valued at approximately $1,024,867.44. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In related news, insider R. Scott Ramsey sold 11,599 shares of the stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $162.06, for a total transaction of $1,879,733.94. Following the completion of the sale, the insider now owns 6,324 shares in the company, valued at $1,024,867.44. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Richard W. Fisher sold 2,000 shares of the stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $163.67, for a total transaction of $327,340.00. Following the sale, the director now owns 14,227 shares of the company’s stock, valued at $2,328,533.09. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 128,203 shares of company stock valued at $19,754,997. Company insiders own 0.93% of the company’s stock.

Tenet Healthcare announced that its Board of Directors has approved a stock buyback program on Wednesday, July 24th that allows the company to buyback $1.50 billion in outstanding shares. This buyback authorization allows the company to buy up to 10.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its stock is undervalued.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.